You can buy or sell OpGen and other stocks, options, and ETFs commission-free!
OpGen, Inc. Common Stock, also called OpGen, is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD. The listed name for OPGN is OpGen, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 23, After Hours